SR-BioPharma Building $32 Million Facility In China Medical City

by Richard Daverman, PhD

March 24, 2014 -- Jiangsu SR-BioPharma Co. has broken ground on a new facility in Taizhou’s China Medical City, where it will make its vaccine for HPV. The facility will cost $32 million to build and be complete in one year. Operations will begin in September 2015. SR-BioPharma expects output from the facility will total $162 million. More details....

Help employers find you! Check out all the jobs and post your resume.